Aripiprazole in the Maintenance Treatment of Bipolar Disorder: A Critical Review of the Evidence and Its Dissemination into the Scientific Literature

BACKGROUND: Aripiprazole, a second-generation antipsychotic medication, has been increasingly used in the maintenance treatment of bipolar disorder and received approval from the U.S. Food and Drug Administration for this indication in 2005. Given its widespread use, we sought to critically review t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Alexander C., Rosenlicht, Nicholas Z., Jureidini, Jon N., Parry, Peter I., Spielmans, Glen I., Healy, David
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086871/
https://www.ncbi.nlm.nih.gov/pubmed/21559324
http://dx.doi.org/10.1371/journal.pmed.1000434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086871/
https://www.ncbi.nlm.nih.gov/pubmed/21559324
http://dx.doi.org/10.1371/journal.pmed.1000434

Ejemplares similares